Emalex Biosciences raises $250 million to treat stuttering and Tourettes
November 03, 2022 at 10:41 AM EDT
Emalex Biosciences announced it closed a $250 million Series D funding round this week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|